Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RIV | us court revives human rights case vs rio tint | 26/10/11 | 1 | 2.5K | |||
|
|||||||
RIV | Ann: Removal from Official List | 06/07/11 | 0 | 1.7K | |||
|
|||||||
RIV | Ann: Suspension from Official Quotation at close | 24/06/11 | 0 | 1.5K | |||
|
|||||||
RIV | Ann: New CEO Appointed | 24/06/11 | 0 | 1.5K | |||
|
|||||||
RIO +RIV | Ann: RIO:Compulsory acquisition of remaining shar | 24/06/11 | 0 | 1.7K | |||
|
|||||||
RIO +RIV | Ann: Notice of change of interests of substantial | 20/06/11 | 0 | 1.4K | |||
|
|||||||
RIO +RIV | Ann: Rio Tinto to move to compulsory acquisition | 17/06/11 | 0 | 1.6K | |||
|
|||||||
RIO +RIV | News: Rio to take full ownership of Riversdale | 17/06/11 | 0 | 1.5K | |||
|
See All Discussions